Low-Dose Antithymocyte Globulin Effective in Preserving Beta-Cell Function in Type 1 Diabetes: Study
Belgium: A phase 2 international trial published in The Lancet has found that low-dose antithymocyte globulin (ATG) can slow ...
Hosted on MSN
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated ...
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback